Blueprint Medicines
James Baker is a seasoned professional in drug metabolism and pharmacokinetics, currently serving as the Senior Director and Head of DMPK at Blueprint Medicines. Additionally, James holds the position of Chairperson for the New England Drug Metabolism Discussion Group. Previously, James contributed expertise as a DMPK scientist at Pfizer, building a solid foundation in the field of pharmaceutical development.
This person is not in any teams
This person is not in any offices
Blueprint Medicines
4 followers
Blueprint Medicines Corporation is a biopharmaceutical company. The Company focuses on patients with genomically defined diseases driven by abnormal kinase activation.